SIGMA C6643-250MG 氯贝丁酯 637-07-0
文献支持

SIGMA C6643-250MG 氯贝丁酯 637-07-

0
收藏
  • ¥552
  • Sigma-Aldrich
  • 进口
  • C6643-250MG
  • 2025年12月03日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      2-8°C

    • 保质期

      根据瓶身LOT号查询

    • 英文名

      Clofibrate

    • 库存

      有现货

    • 供应商

      浙江羽翔生物科技有限公司

    • CAS号

      637-07-0

    • 规格

      250MG

    属性

    表单

    liquid

    质量水平

    200

    颜色

    clear colorless

    密度

    1.14 g/mL at 25 °C (lit.)

    创始人

    Wyeth

    储存温度

    2-8°C

    SMILES字符串

    CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1

    InChI

    1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3

    InChI key

    KNHUKKLJHYUCFP-UHFFFAOYSA-N

    基因信息

    human ... PPARA(5465)
    mouse ... Ppara(19013)

    应用

    Clofibrate has been used:
    • as a quinolinate phosphoribosyltransferase (QPRT) agonist to study its effects on hepatitis C virus (HCV) infection
    • as peroxisome proliferated activated receptor (PPAR) agonist to study its effects on autophagy in rat liver cells
    • as a hepatotoxicant to study its effects on gene expression in primary rat hepatocytes

    生化/生理作用

    Clofibrate is a peroxisome proliferated activated receptor α (PPARα) agonist. It is a fibric acid derivative and has a therapeutic effect on hypertriglyceridemia and hyperlipoproteinemia type III. Clofibrate participates in lowering the very-low-density lipoprotein (VLDL) and cholesterol levels in hyperlipoproteinemia type III patients. It facilitates the decrease of total serum bilirubin concentration in Gilbert′s syndrome.

    特点和优势

    This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
    This compound was developed by Wyeth. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

    包装

    Bottomless glass bottle. Contents are inside inserted fused cone.
     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    Probing the fibrate binding specificity of rat liver fatty acid binding protein.

    Journal of medicinal chemistry (2009-08-12)
    Sara Chuang, Tony Velkov, James Horne, Jerome Wielens, David K Chalmers, Christopher J H Porter, Martin J Scanlon
    PMID19663428
    摘要

    Liver-fatty acid binding protein (L-FABP) is found in high levels in enterocytes and is involved in cytosolic solubilization of fatty acids. In addition, L-FABP has been shown to bind endogenous and exogenous lipophilic compounds, suggesting that it may also play a role in modulating their absorption and disposition within enterocytes. Previously, we have described binding of L-FABP to a range of drugs, including a series of fibrates. In the present study, we have generated structural models of L-FABP-fibrate complexes and undertaken thermodynamic analysis of the binding of fibrates containing either a carboxylic acid or ester functionality. Analysis of the current data reveals that both the location and the energetics of binding are different for fibrates that contain a carboxylate compared to those that do not. As such, the data presented in this study suggest potential mechanisms that underpin molecular recognition and dictate specificity in the interaction between fibrates and L-FABP.

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥615
    嘉兴亦高医疗器械有限公司
    2025年10月03日询价
    ¥33
    上海源叶生物科技有限公司
    2025年10月29日询价
    询价
    谱析(上海)生物科技有限公司
    2025年07月14日询价
    ¥1112
    浙江羽翔生物科技有限公司
    2025年09月12日询价
    ¥2220
    浙江亦高生物科技有限公司
    2025年12月18日询价
    文献支持
    SIGMA C6643-250MG 氯贝丁酯 637-07-0
    ¥552